Pomalyst
Active Ingredient(s): PomalidomideFDA Approved: * February 8, 2013
Pharm Company: * CELGENE
Category: Cancer
Pomalidomide (INN; marketed as Pomalyst in the US[3] and Imnovid in the European Union and Russia) is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator.[medical citation needed] Pomalidomide was approved in February 2013, by the US Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.[6] It has been approved for use in people who have received at ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Popular Topics
Pomalyst
Started about a year ago after revlimid quit working. Still adjusting the dosage. Gone from 4 to 1 to 2 to 3 mg. Mostly ...